Page last updated: 2024-12-07

trimeperidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Promedol: A narcotic analgesic similar to MEPERIDINE; it exists in four stereoisomers, two of which, the beta (isopromedol) and the gamma (trimeperidine) are active. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID98520
CHEMBL ID2107685
SCHEMBL ID25236
MeSH IDM0017702

Synonyms (23)

Synonym
trimeperidine
promedol
64-39-1
1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine
4-piperidinol, 1,2,5-trimethyl-4-phenyl-, propionate (ester)
4-piperidinol, 1,2,5-trimethyl-4-phenyl-, propanoate (ester)
4-piperidinol, 4-phenyl-1,2,5-trimethyl-, propionate
CHEMBL2107685
.gamma.-promedol
isopromedol-
trimeperidin
ids-nt-004
SCHEMBL25236
4-piperidinol, 1,2,5-trimethyl-4-phenyl-, propanoate
4-piperidinol, 1,2,5-trimethyl-4-phenyl-, propionate
1,2,5-trimethyl-4-phenyl-4-piperidinol, propionate
1,2,5-trimethyl-4-phenyl-4-piperidinyl propionate #
UVITTYOJFDLOGI-UHFFFAOYSA-N
Q4463083
29606-10-8 (free base)
1,2,5-trimethyl-4-phenylpiperidin-4-yl propionate
1,2,5-trimethyl-4-phenylpiperidin-4-yl propanoate
DTXSID90861607

Research Excerpts

Dosage Studied

The dosage of narcotics can be decreased (that of trimeperidine on an average from 80 to 45 mg/day) in the early postoperative period if non-narcotic analgesics, such as paracetamol 4 g/day, are incorporated into the regimen.

ExcerptRelevanceReference
"Prosidol, a new Russian narcotic analgesic, was used in various dosage forms (buccal and oral tablets, injection solution) in 113 cancer patients for the treatment of chronic pain, as a component of total anesthesia, and for postoperative analgesia."( [First experience in the use of a new Russian narcotic analgesic prosidol in oncology].
Beresnev, VA; Loseva, NA; Novikov, GA; Osipova, NA; Prokhorov, BM; Smolina, TA; Vetsheva, MS; Zemskaia, SIu,
)
0.13
" The potential of antipyrine phenotyping for individualisation of anesthetics' dosing is discussed."( [Phenotyping by total oxidative hepatic capacity in patients undergoing laparoscopic cholecystectomy: two categories of patients and duration of post-anesthesia rehabilitation].
Chuenkova, EA; Ziganshina, LE, 2013
)
0.39
" The dosage of narcotics can be decreased (that of trimeperidine on an average from 80 to 45 mg/day) in the early postoperative period if non-narcotic analgesics, such as paracetamol 4 g/day, are incorporated into the analgesic regimen."( [Analgesia in hemophiliac patients during orthopedic surgery].
Gemdzhian, ÉG; Gorodetskiĭ, VM; Koniashina, NI; Krechetova, AV; Levchenko, OK; Shulutko, EM, 2014
)
0.65
"Analysis of the results of pharmacological phenotyping using antipyrine test prior to providing anesthesia for laparoscopic cholecystectomy showed that trimeperidine (promedol) dosing with allowance for the total oxidative capacity of liver and the patient mass allows the periods of post-anesthetic rehabilitation to be controlled."( POST-ANESTHETIC REHABILITATION PERIODS AND ANESTHESIA DOSAGE FOR LAPAROSCOPIC CHOLECYSTECTOMY: RELATIONSHIP TO THE TOTAL OXIDATIVE CAPACITY OF LIVER.
Chuenkova, EA; Simushkin, SV; Ziganshina, LE, 2016
)
0.63
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (64)

TimeframeStudies, This Drug (%)All Drugs %
pre-199047 (73.44)18.7374
1990's6 (9.38)18.2507
2000's2 (3.13)29.6817
2010's8 (12.50)24.3611
2020's1 (1.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.17 (24.57)
Research Supply Index5.17 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index62.80 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials21 (13.64%)5.53%
Reviews4 (2.60%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other129 (83.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]